MIGS Device System
Glaucoma
CommercialMarket approved in China
Key Facts
About Micropoint Biotechnologies
Chinese ophthalmic medical device company developing minimally invasive surgical technologies for glaucoma and retinal diseases.
View full company profileTherapeutic Areas
Other Glaucoma Drugs
| Drug | Company | Phase |
|---|---|---|
| PREZIA Glaucoma Implant | PolyActiva | Preclinical |
| INM-088 | InMed Pharmaceuticals | Preclinical |
| OT-401 | Ocumension Therapeutics | Phase 2 |
| ANX007 | Annexon Biosciences | Phase 2 |
| PER-001 | Perfuse Therapeutics | Phase 2 |
| hOTX2 | BrainEver | Discovery |
| Glaucoma Treatment | BVI Medical | Commercial |
| MediPrint Lens (Glaucoma) | MediPrint Ophthalmics | Phase 2b |
| Glaucoma Program | Broadwing Bio | Pre-clinical |
| MSC Exosomal Eye Serum | Vitti Labs | Pre-clinical |
| BTQ1902 | Betaliq | Phase 2 |
| TODDD™ Platform | Amorphex Therapeutics | Pre-clinical |